Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 97

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 97
---
 series
of debt securities, unless such holders have offered the debenture trustee reasonable indemnity. The holders of a majority in principal
amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding
for any remedy available to the debenture trustee, or exercising any trust or power conferred on the debenture trustee, with respect to
the debt securities of that series, provided that:

| · | the direction so given by the holder is not in conflict with any law or the applicable indenture; and |

| · | subject to its duties under the Trust Indenture Act, the debenture trustee need not take any action that             
 might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding. |

A holder of the debt securities
of any series will only have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek
other remedies if:

| · | these limitations do not apply to a suit instituted by a holder of debt securities if we default in the 
 payment of the principal, premium, if any, or interest on, the debt securities;                         |

| · | the holder previously has given written notice to the debenture trustee of a continuing event of default 
 with respect to that series;                                                                             |

| · | the holders of at least a majority in aggregate principal amount of the outstanding debt securities of                                         
 that series have made written request, and such holders have offered reasonable indemnity to the debenture trustee to institute the proceeding 
 as trustee; and                                                                                                                                |

| · | the debenture trustee does not institute the proceeding, and does not receive from the holders of a majority                              
 in aggregate principal amount of the outstanding debt securities of that series (or at a meeting of holders of such series at which a     
 quorum is present, the holders of a majority in principal amount of the debt securities of such series represented at such meeting) other 
 conflicting directions within 60 days after the notice, request and offer.                                                                |

We will periodically file
statements with the applicable debenture trustee regarding our compliance with specified covenants in the applicable indenture.

Modification of Indenture; Waiver

The debenture trustee and
we may change the applicable indenture without the consent of any holders with respect to specific matters, including:

| · | to fix any ambiguity, defect or inconsistency in the indenture; and